Aerolase and Eucerin Join Forces to Optimize Patient Outcomes in Laser Treatments

Both companies will develop therapies for adjunctive care post-laser treatments.

Aerolase and Eucerin are working together to optimize laser treatment protocols in the D-A-CH-region (Germany-Austria-Switzerland).

Furthermore, both companies will develop therapies for adjunctive care post-laser treatments. Both companies will also conduct a joint symposium at the upcoming German congress FOBI (27th Fortbildungswoche für praktische Dermatologie und Venerologie) in July 2020.

"We see a lot of innovation coming up in the medical device business and are always looking for innovative partnerships. Combining laser treatments with our medical skin care expertise enables us to provide even better results for patients and their quality of life," says Martin Wulle, General Manager EMEA, Dermo Cosmetics, Beiersdorf, in a news release.

Pavel Efremkin PhD, Chairman and CEO of Aerolase adds,: "We see great potential in this collaboration, and are confident the laser and adjunctive care protocols will elevate standards of care. Future breakthrough therapies will likely come through innovative clinical research, technologies and proprietary combination treatments."